Follence Medicated - CISNE GROUP LLC

Manufacturer
CISNE GROUP LLC
Effective date
2026-05-06
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:56:16

Label at a glance#

ProductFollence Medicated
Active ingredientSALICYLIC ACID
Label structure7 sections

Label contents#

Full prescribing information#

INDICATIONS & USAGE SECTION

Controls dandruff. Helps relieve and prevent recurrence of itching, flaking, and irritation associated with dandruff, seborrheic dermatitis, and psoriasis.

WARNINGS SECTION

For external use only.

Do not use if you are allergic to any of the ingredients in this product.

When using this product:
Avoid contact with eyes. In case of contact, rinse eyes thoroughly with water.

Stop use and ask a doctor if condition worsens or does not improve after regular use.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center immediately.

INACTIVE INGREDIENT SECTION

Aqua
Sodium C14-16 Olefin Sulfonate
Cocamidopropyl Betaine
Sodium Methyl Cocoyl Taurate
Hexylene Glycol
Niacinamide
Glycerin
Sodium Chloride
Panthenol
Piroctone Olamine
PEG-40 Hydrogenated Castor Oil
Phenoxyethanol
Menthol
Centella Asiatica Extract
Allantoin
Melaleuca Alternifolia (Tea Tree) Extract

DOSAGE & ADMINISTRATION SECTION

Wet hair thoroughly. Apply sufficient amount of shampoo to scalp and massage into a lather. Leave on the scalp for several minutes to allow the active ingredient to work. Rinse thoroughly and repeat if needed.

Use at least twice a week or as directed by a doctor.

For best results, use regularly.

OTC - PURPOSE SECTION

Active ingredient: Salicylic Acid 3%
Purpose: Anti-dandruff / Keratolytic

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LabelingLabelingMedicated shampoo formulated with Salicylic Acid 3% to help control dandruff and relieve symptoms associated with seborrheic dermatitis and psoriasis. Helps reduce flaking, itching, irritation, and scalp buildup.

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
87667-002-01Follence Medicated360 mL in 1 BOTTLESHAMPOO3601

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 18 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
87667-00287667-002-01
84484-002

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 17 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Follence MedicatedSALICYLIC ACIDCISNE GROUP LLC512abbb6-ea6a-70b1-e063-6294a90a2a7c2026-05-06WarningsExact identifier
ndc (package): 87667-002-01
ndc (product): 87667-002
ndc11 (package): 87667000201
spl id: 512aafab-bca1-c5db-e063-6394a90a8496
spl set id: 512abbb6-ea6a-70b1-e063-6294a90a2a7c
Follence MedicatedSALICYLIC ACIDGuangzhou Pallas Cosmetics Co.,Ltd.51178cb9-f83f-2459-e063-6394a90a3f1e2026-05-05WarningsExact identifier
ndc (product): 84484-002

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.